NovoLog (insulin aspart) is a brand-name injectable solution that’s prescribed for type 1 and type 2 diabetes. NovoLog has interactions with alcohol, some other drugs, and certain supplements.

Kirsty 100units/mL is supplied as a 3 mL single-patient-use prefilled pen as well as a 10 mL multiple-dose vial. The approval of insulin aspart-xjhz was supported by a comprehensive data package that ...

Merilog, a biosimilar to Novolog, offers a more affordable insulin option for type 2 diabetes patients, enhancing treatment accessibility. The GEMELLI-1 trial confirmed Merilog's noninferiority to the ...

Walmart is looking to make waves in the diabetes space with the first-ever private-brand analog insulin. Walmart's ReliOn NovoLog was announced Wednesday, with executives noting that the insulin ...

NOVOLOG (insulin aspart) 100Units/mL by Novo Nordisk The FDA approved a labeling change to NovoLog (insulin aspart [rDNA origin] injection, from Novo Nordisk) that allows patients with diabetes to use ...

BENTONVILLE, Ark.--(BUSINESS WIRE)--Walmart announced the launch of the first-ever private brand analog insulin, which will revolutionize the access and affordability to diabetes care by offering ...

However, an earlier study also performed in subjects with type 1 diabetes found some differences in pharmacokinetic parameters between the 2 agents. Fourteen subjects were randomized to a single dose ...

Novo Nordisk announced that the FDA has approved its insulin aspart injection Fiasp, which can rapidly improve glycemic control at mealtimes for patients with type 1 and type 2 diabetes. Novo Nordisk ...

Sept. 15, 2005 — The U.S. Food and Drug Administration (FDA) and Novo Nordisk, Inc., have notified pharmacists via letter of changes to the packaging for a rapid-acting insulin analog (NovoLog) that ...

(RTTNews) - Danish pharmaceutical company Novo Nordisk A/S is recalling 1,468 product samples of Levemir, Tresiba, Fiasp, Novolog and Xultophy to the consumer level, due to improper storage ...